UniSa - IRIS Institutional Research Information System

SELLERI, Carmine
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.701
AS - Asia 10.230
EU - Europa 5.460
SA - Sud America 655
AF - Africa 73
Continente sconosciuto - Info sul continente non disponibili 28
OC - Oceania 13
Totale 34.160
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.584
HK - Hong Kong 6.336
SG - Singapore 1.361
CN - Cina 1.245
UA - Ucraina 1.190
IT - Italia 1.059
DE - Germania 986
RU - Federazione Russa 735
BR - Brasile 586
FI - Finlandia 482
VN - Vietnam 460
IE - Irlanda 429
KR - Corea 295
TR - Turchia 275
SE - Svezia 181
AT - Austria 104
GB - Regno Unito 100
IN - India 100
CA - Canada 75
CZ - Repubblica Ceca 42
JP - Giappone 39
NL - Olanda 29
EU - Europa 28
ES - Italia 27
PL - Polonia 27
AR - Argentina 25
MX - Messico 25
BD - Bangladesh 23
ET - Etiopia 23
ZA - Sudafrica 19
FR - Francia 18
PK - Pakistan 13
VE - Venezuela 13
EC - Ecuador 12
UZ - Uzbekistan 11
IQ - Iraq 10
LT - Lituania 10
AU - Australia 9
JO - Giordania 9
AE - Emirati Arabi Uniti 8
ID - Indonesia 8
CH - Svizzera 7
EG - Egitto 7
KE - Kenya 7
MA - Marocco 6
PE - Perù 6
CL - Cile 5
HU - Ungheria 5
PS - Palestinian Territory 5
SA - Arabia Saudita 5
HN - Honduras 4
KG - Kirghizistan 4
LU - Lussemburgo 4
NZ - Nuova Zelanda 4
BE - Belgio 3
BG - Bulgaria 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
IL - Israele 3
LV - Lettonia 3
MK - Macedonia 3
MY - Malesia 3
RS - Serbia 3
TN - Tunisia 3
UY - Uruguay 3
BB - Barbados 2
BO - Bolivia 2
BZ - Belize 2
CR - Costa Rica 2
HR - Croazia 2
IR - Iran 2
LK - Sri Lanka 2
LY - Libia 2
NI - Nicaragua 2
OM - Oman 2
PH - Filippine 2
PY - Paraguay 2
RO - Romania 2
SN - Senegal 2
TJ - Tagikistan 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
NG - Nigeria 1
NP - Nepal 1
PA - Panama 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TW - Taiwan 1
Totale 34.160
Salva come PNG Salva come JPEG
Città #
Hong Kong 6.322
Ann Arbor 4.703
Woodbridge 2.446
Jacksonville 1.460
Chandler 1.347
Houston 1.164
Princeton 1.164
Wilmington 1.110
Ashburn 554
Singapore 524
Munich 451
Dong Ket 422
Dublin 407
Andover 283
Nanjing 258
Beijing 248
Izmir 246
Boardman 245
Moscow 217
Salerno 208
Pellezzano 171
Helsinki 152
Düsseldorf 145
Naples 129
Fairfield 100
Los Angeles 100
Shenyang 90
Nuremberg 87
Nanchang 86
Changsha 84
Jiaxing 80
Hebei 77
Dallas 67
Turku 62
Washington 56
Redwood City 55
São Paulo 53
New York 52
Norwalk 48
Brooklyn 47
Rome 46
Tianjin 46
Vienna 44
Pune 39
Dearborn 37
Brno 36
Napoli 36
Santa Clara 36
Cambridge 34
Seattle 33
Council Bluffs 31
San Francisco 30
Columbus 29
The Dalles 28
San Diego 27
Boston 25
London 25
Rio de Janeiro 25
Addis Ababa 23
Chicago 23
Milan 23
Warsaw 23
Guangzhou 22
Jinan 21
Phoenix 21
Tokyo 21
Mestre 20
Belo Horizonte 19
Stockholm 19
Falls Church 18
Toronto 18
Charlotte 17
Grevenbroich 17
Jyväskylä 17
Ottawa 17
Fisciano 16
Ho Chi Minh City 15
Amsterdam 14
Atlanta 14
Lappeenranta 14
Manchester 14
Montreal 13
Zhengzhou 13
Chennai 12
Johannesburg 12
Mumbai 12
Shanghai 12
Brasília 11
Tappahannock 11
Tashkent 11
Caserta 10
Curitiba 10
Hillsboro 10
Amman 9
Buffalo 9
Contagem 9
Cava de' Tirreni 8
Hefei 8
Indiana 8
New Delhi 8
Totale 26.749
Salva come PNG Salva come JPEG
Nome #
The metastasis-associated 67-kDa laminin receptor is involved in G-CSF-induced hematopoietic stem cell mobilization. 880
Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study 855
Computer aided identification of small molecules interfering with the functional interaction of the urokinase receptor with fMLP receptors 503
Mucosal-Associated Invariant T Cells in T-Cell Non-Hodgkin Lymphomas: A Case Series 381
Hodgkin Lymphoma and Hairy Cell Leukemia Arising from Chronic Lymphocytic Leukemia: Case Reports and Literature Review 373
Inhibition of interferon regulatory factor-1 expression results in predominance of cell growth stimulatory effects of interferon-gamma due to phosphorylation of Stat1 and Stat3. 310
Endocrine disorders during the first year after autologous stem-cell transplant. 303
Low-Density Granulocytes Are Decreased in Acute Myeloid Leukemia and in Myelodysplastic Syndromes with Negative Prognostic Factors 296
A Rare Immune-Related Mesenteric and retroperitoneal serositis in a Multi-Refractory Hodgkin Lymphoma Patient Successfully Treated with Chylolymphostatic Surgery 260
Involvement of soluble forms of receptor of the urokinase-type plasminogen activator (UPAR) in hematopoietic stem cell homing 257
2-deoxy-2-(18F)fluoro-D-glucose positron emission tomography/computed tomography in primary extranodal lymphomas: treatment response evaluation and prognosis 234
Aplastic anemia: Pathophysiology 219
67 KDA laminin receptor expression in human G-CSF mobilized CD34(+) peripheral blood stem cells correlates with their mobilization efficiency 214
Development and Validation of a Reverse-Phase High-Performance Liquid Chromatography with Fluorescence Detection (RP-HPLC-FL) Method to Quantify Ruxolitinib in Plasma Samples 213
Expression and function of the 67kDa laminin receptor in normal and acute leukemia cells 189
Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha. 186
Giant plasma cells with multiple immature nuclei in a young woman with newly diagnosed multiple myeloma 183
A novel approach to cell targeted complement inhibition in PNH: the human complement receptor 2/Factor H fusion protein TT30 prevents both hemolysis and upstream C3-opsonization of PNH erythrocytes 180
The urokinase-receptor in infectious diseases. 175
Post-therapy B regulatory cells might early predict relapse in Hodgkin lymphoma 173
Involvement of urokinase receptor in the cross-talk between human hematopoietic stem cells and bone marrow microenvironment 163
Efficacy and safety of new direct antiviral agents in HCV infected patients with Diffuse Large B Cell Non-Hodgkin Lymphoma 158
Function and malfunction of hematopoietic stem cells in primary bone marrow failure syndromes. 149
Autologous And Allogeneic Stem Cell Transplantation Is Associated With Long-Lasting Endocrine Disorders 144
Unresponsiveness to erythropoietin therapy in a case of Blackfan Diamond anemia. 143
Role of the urokinase receptor in hematopoietic stem cell transplantation 141
Soluble forms of UPAR regulate adhesion, proliferation and survival of KG1 leukemic cells 141
Bendamustine in combination with rituximab as first line therapy for patients with chronic lymphocytic leukemia (cll): a retrospective real practice italian multicentre study. 139
The cleaved form of soluble urokinase-receptor stimulates migration and mobilization of mouse CD34(+) cells in vitro and in vivo 139
Accelerated and persistent bone loss after autologous and allogeneic stem cell transplantation 137
High incidence of cytomegalovirus reactivation in patients with lymphoma treated with bendamustine 137
Urokinase receptor and CXCR4 are regulated by common microRNAs in leukaemia cells 137
Lenalidomide-Mediated NK Cells Expansion In Elderly Multiple Myeloma Patients 136
WT1 Expression Levels Combined with Flow Cytometry Blast Counts for Risk Stratification of Acute Myeloid Leukemia and Myelodysplastic Syndromes 134
Immature forms of low density granulocytes are increased in acute myeloid leukemia and myelodysplastic syndromes 132
Cell-free regenerative medicine: identifying the best source of mesenchymal stem cells for skin therapy in Systemic Sclerosis 131
A candidate complement inhibitor for the treatment of paroxysmal nocturnal haemoglobinuria (PNH): preclinical data with tt30, a therapeutic that selectively blocks the complement alternative pathway. 130
The Role of B Regulatory Cells in the Immunological Escape of Tumor Cells in Hodgkin Lymphoma 129
Involvement of Fas-mediated apoptosis in the inhibitory effects of interferon-alpha in chronic myelogenous leukemia 128
Continuous maintenance therapy with alternate-day low dose lenalidomide in multiple myeloma patients after autologous stem cell transplantation increases the number of circulating natural killer cells 127
High dose rHuEPO may induce complete remission in AML-M6 126
A backwards evolution in a case of myeloproliferative disease 126
Continuous alternate-day low dose lenalidomide in combination with low dose prednisone as frontline treatment for octogenarian newly diagnosed multiple myeloma patients 126
High frequency of extramedullary relapse in patients transplanted for acute myeloid leukemia. 123
Anaplastic CD30+ alk- (micro) lymphoma arising out of mediastinal Plasma Cell Castleman’s disease in immunocompetent patient treated by rituximab- dexametasone and continuous lenalidomide 123
Allogeneic transplantation for multiple myeloma 122
Prolonged low-dose lenalidomide treatment increases the number of circulating natural killer cells in multiple mieloma patients 120
Hemopoiesis and Immune Cell Perturbations during Venetoclax Plus Azacytidine Treatment in Acute Myeloid Leukemia 119
Adjuvant treatment of diabetic foot 119
A GITMO randomised trial in steroid refractory acute graft-versus-host disease: 6methylprednisolone with or without anti-thymocyte globulin 118
67 kDa laminin receptor: structure, function and role in cancer and infection. 118
Impact of cytokine gene polymorphisms in myelodysplastic syndromes (MDS) 117
Two year follow-up of cyclosporin-A in hypoplastic myelodysplastic leukemia. 117
A novel crosstalk between calcium/calmodulin kinases II and IV regulates cell proliferation in myeloid leukemia cells 117
Subcutaneous low-dose IL-2 for remission maintenance in elderly acute myeloid leukemia patients. 116
Higher expression of Fas receptor on CD34+ cells of chronic myelogenous leukemia correlates with hematological response to IFN-alfa. 116
Blockade of intravascular hemolysis in PNH with the terminal complement inhibitor eculizumab unmasks low-level hemolysis potentially occurring through C3 opsonization 115
Fluorescent in situ hybridization with a Y probe in the follow up of sex-mismatch transplanted patients 115
Prolonged azacitidine treatment in the management of elderly patients with high risk myelodysplastic syndromes, chronic myelomonocytic leukemia and acute myeloid leukemia not eligible for standard intensive therapy 115
CD10, BCL6, and MUM1 expression in diffuse large B-cell lymphoma on FNA samples 115
Expression of the 67 kDa laminin receptor in acute myeloid leukemia cells mediates adhesion to laminin and is frequently associated with monocytic differentiation 114
Bone marrow mesenchymal stem cells as a possible ruxolitinib reservoir in the bone marrow niche 114
Fas-mediated downmodulation of p210 BCR/ABL results in apoptosis of CD34+ cells of chronic myelogenous leukemia. 113
Prophylactic therapy with oral low-dose valgancyclovir in cytomegalovirus-positive allogeneic stem cell transplant recipients 113
IgH assessment of non-Hodgkin lymphoma cells on FTA cards. 113
Multicenter Experience Using Total Lymphoid Irradiation and Antithymocyte Globulin as Conditioning for Allografting in Hematological Malignancies 112
Impact of cytokine gene polymorphism in aplastic anemia (AA) 112
Discovery of new small molecules inhibiting 67 kDa laminin receptor interaction with laminin and cancer cell invasion 111
A randomized trial of bone marrow (BM) versus peripheral blood (PB) allogeneic hemopoietic stem cell transplants (HSCT) in patients with myeloproliferative disorders. 110
67 KDA laminin receptor (67LR) in normal and neoplastic hematopoietic cells: is its targeting a feasible approach? 110
DECREASED LOW-DENSITY GRANULOCYTES AS POSSIBLE DIAGNOSTIC MARKERS OF MYELODYSPLASTIC SYNDROMES WITH EXCESS OF BLASTS 109
A novel chromosomal abnormality detected in a case of acute myelomonocytic leukemia. 109
Effects of leptin and IGF-1 on bone mineral density in long-term survivors after allogeneic stem cell transplantation for hematological malignancies 109
Increased expression of the signaling lymphocyte-activation molecule (mSLAM) in patients with paroxysmal nocturnal hemoglobinuria (PNH). 109
Complementary and alternative medicine use in patients with chronic lymphocytic leukemia: an Italian multicentric survey 109
67 KDa laminin receptor (67LR) expression and function in normal and acute myeloid leukemia CD34(+) cells 108
Long-term follow-up of a pilot study with alemtuzumab and low-dose cyclosporine a for aplastic anaemia and single-lineage marrow failures. 108
Subcutaneous alemtuzumab is safe and effective for treatment of global or single-lineage immune-mediated marrow failure: a pilot study from the working party aplastic anaemia (WPSAA) 108
Bendamustine in Combination with Rituximab for Previously Untreated Chronic Lymphocytic Leukemia (CLL) Patients: An Italian Retrospective Multicentre Study 108
Ultrasound image of pleural granulocytic sarcoma. 107
Estrogen-progestin-replacement therapy in women after stem cell transplant 107
Paroxysmal nocturnal hemoglobinuria (PNH) in the eculizumab era: The bedside and beyond. 107
FAS antigen expression on normal and aplastic CD34+ cells. 107
Achievements and limitations of complement inhibition by eculizumab in paroxysmal nocturnal hemoglobinuria: the role of complement component 3. 106
Fas-Ligand expressed on acute leukemia cells may kill Fas positive Jurkat cells. 106
Imatinib as salvage therapy for patients with refractory cGVHD 106
Efficacy and safety of splenectomy in adult autoimmune hemolytic anemia. 106
Measurement of secondary colony formation after 5 weeks in long-term cultures in patients with myelodysplastic syndrome. 105
Previous occurrence of life-threatening abdominal infection is not a contraindication to marrow transplant. 105
Induction therapy with continuous alternate-day low dose lenalidomide combined with low-dose prednisone in octogenarian Multiple Myeloma patients 105
Complete phenotypic and genotypic lineage switch in a Philadelphia chromosome-positive acute lymphoblastic leukemia. 103
Effects of cyclosporine on hematopoietic and immune functions in patients with hypoplastic myelodysplasia: in vitro and in vivo studies. 103
Inhibition of interferon regulatory factor-1 expression induces interferon-gamma to stimulate CD34+ cells. 103
Nitric oxide and cell survival: megakaryocytes say "NO". 102
Sustained long-term hematologic recovery despite a marked quantitative defect in the stem cell compartment of patients with aplastic anemia after immunosuppressive therapy. 102
Bone marrow long-term initiating cells are decreased after allogeneic bone marrow transplantation. 102
Bendamustine in combination with rituximab for elderly patients with aggressive B non hodgkin lymphoma not eligible for anthracycline-based therapy 102
miRNA-MEDIATED CO-REGULATION OF UROKINASE RECEPTOR AND CXCR4 EXPRESSION 102
Fine needle aspiration cytology of lymphoproliferative lesions of the oral cavity 102
A severe and consistent deficit in marrow and circulating primitive hematopoietic cells (long-term culture-initiating cells) in acquired aplastic anemia. 101
Totale 15.830
Salva come PNG Salva come JPEG
Categoria #
all - tutte 109.718
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.718
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.307 0 242 248 11 328 74 266 25 247 36 357 473
2021/20222.072 21 9 15 65 58 61 21 74 309 273 267 899
2022/20233.454 333 179 103 358 477 728 52 354 560 22 176 112
2023/20241.769 182 250 131 101 144 264 75 93 16 68 105 340
2024/20254.744 165 77 63 149 223 610 880 501 672 253 500 651
2025/20267.166 2.517 4.649 0 0 0 0 0 0 0 0 0 0
Totale 34.846